BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32410863)

  • 21. Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between
    Bae SC; Lee YH
    Postgrad Med J; 2018 Feb; 94(1108):109-115. PubMed ID: 28912189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population.
    Wu J; Fu S; Ren X; Jin Y; Huang X; Zhang X; Bai J; Fu S
    Tissue Antigens; 2009 Apr; 73(4):302-6. PubMed ID: 19317738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association between MIF gene -173G>C polymorphism with multiple sclerosis.
    Cevik B; Yigit S; Karakus N; Aksoy D; Ates O; Kurt S
    In Vivo; 2015; 29(1):71-6. PubMed ID: 25600533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunobiology of MIF: function, genetics and prospects for precision medicine.
    Kang I; Bucala R
    Nat Rev Rheumatol; 2019 Jul; 15(7):427-437. PubMed ID: 31197253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
    Santoscoy-Ascencio G; Baños-Hernández CJ; Navarro-Zarza JE; Hernández-Bello J; Bucala R; López-Quintero A; Valdés-Alvarado E; Parra-Rojas I; Illades-Aguiar B; Muñoz-Valle JF
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1037. PubMed ID: 31701681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome.
    Karakaya B; van Moorsel CH; van der Helm-van Mil AH; Huizinga TW; Ruven HJ; van der Vis JJ; Grutters JC
    Cytokine; 2014 Oct; 69(2):272-6. PubMed ID: 24951298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor-794 CATT microsatellite polymorphism and risk of tuberculosis: a meta-analysis.
    Ma M; Tao L; Liu A; Liang Z; Yang J; Peng Y; Dai X; Bai R; Ji Z; Jian M; Bao F
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29773680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
    Hernández-Palma LA; García-Arellano S; Bucala R; Llamas-Covarrubias MA; De la Cruz-Mosso U; Oregon-Romero E; Cerpa-Cruz S; Parra-Rojas I; Plascencia-Hernández A; Muñoz-Valle JF
    Cytokine; 2019 Mar; 115():89-96. PubMed ID: 30467094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MIF -173G/C gene polymorphism increase gastrointestinal cancer and hematological malignancy risk: evidence from a meta-analysis and FPRP test.
    Tong X; Zheng B; Tong Q; Liu S; Peng S; Yang X; Fan H
    Int J Clin Exp Med; 2015; 8(9):15949-57. PubMed ID: 26629098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].
    Li C; Zhan Y; Li GZ; Liu SG
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):342-6. PubMed ID: 22883521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between MIF-173G/C polymorphism and cerebral stroke.
    Zhong L; Qiao PP; Wang BL; Liu C
    J Biol Regul Homeost Agents; 2020; 34(5):1757-1761. PubMed ID: 33179462
    [No Abstract]   [Full Text] [Related]  

  • 32. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia.
    Arikan C; Berdeli A; Ozgenc F; Tumgor G; Yagci RV; Aydogdu S
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):77-82. PubMed ID: 16385258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the
    Fouda H; Ibrahim WN; Shi Z; Alahmadi F; Almohammadi Y; Al-Haidose A; Abdallah AM
    Front Cardiovasc Med; 2024; 11():1323423. PubMed ID: 38476376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases.
    Renner P; Roger T; Calandra T
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S513-9. PubMed ID: 16237655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Meta-analysis of the association between angiotension-converting enzyme I/D polymorphism and susceptibility to children with Henoch-Schönlein purpura or Henoch-Schölein purpura nephritis].
    Li H; Zhao D; Yang Q
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(26):2039-44. PubMed ID: 25312666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MIF -173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population.
    Xue Y; Xu H; Rong L; Lu Q; Li J; Tong N; Wang M; Zhang Z; Fang Y
    Leuk Res; 2010 Oct; 34(10):1282-6. PubMed ID: 20447688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia.
    Awandare GA; Martinson JJ; Were T; Ouma C; Davenport GC; Ong'echa JM; Wang W; Leng L; Ferrell RE; Bucala R; Perkins DJ
    J Infect Dis; 2009 Aug; 200(4):629-37. PubMed ID: 19591577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism and expression of macrophage migration inhibitory factor does not contribute to glucocorticoid resistance in idiopathic thrombocytopenic purpura.
    Lao W; Xiang Y; Fang M; Yang X
    Pharmazie; 2013 Oct; 68(10):846-9. PubMed ID: 24273891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.